AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use--improves psoriasis in a human xenograft transplantation model.
about
AZ17: a new bispecific drug targeting IL-6 and IL-23 with potential clinical use--improves psoriasis in a human xenograft transplantation model.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
AZ17: a new bispecific drug ta ...... nograft transplantation model.
@en
AZ17: a new bispecific drug ta ...... nograft transplantation model.
@nl
type
label
AZ17: a new bispecific drug ta ...... nograft transplantation model.
@en
AZ17: a new bispecific drug ta ...... nograft transplantation model.
@nl
prefLabel
AZ17: a new bispecific drug ta ...... nograft transplantation model.
@en
AZ17: a new bispecific drug ta ...... nograft transplantation model.
@nl
P2093
P2860
P356
P1476
AZ17: a new bispecific drug ta ...... enograft transplantation model
@en
P2093
Aijun A Wang
Cecilia Rosada
Gordon King
Jeffrey Johnson
Karin Stenderup
Kenneth C Thornton
Kenneth H Grabstein
Kurt Shanebeck
P2860
P304
P356
10.1093/PROTEIN/GZV034
P577
2015-08-12T00:00:00Z